Breaking News

Ajinomoto Completes Althea Acquisition

Will operate under the name Ajinomoto Althea

Ajinomoto Co., Inc. has completed its acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for approximately $175 million. Althea will become a fully consolidated subsidiary of Ajinomoto Co. operating under the company name Ajinomoto Althea, Inc.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters